Skip to main content
. 2015 Jun 12;10:951–961. doi: 10.2147/CIA.S69278

Table 1.

Mechanisms of cell death by anti-CD20 monoclonal antibodies

Rituximab Ofatumumab Obinutuzumab
Antibody type Type I Type I Type II
Format Chimeric Humanized Humanized
CD20 binding site Large loop Large and small loops, closer to cell membrane Large loop
Localization to lipid rafts Yes Yes No
Complement-dependent cytotoxicity High High Low
Antibody-dependent cellular cytotoxicity Low Low High
Direct cell death Low Low High